Skip Nav

Contact Us

Chondrosarcoma CS Foundation, Inc.

Thank you for your interest in our company. Complete the form below to send us an email, or simply give us a call. We're looking forward to working with you.

  • 301-352-3042

    Uncategorized Posts

    Chondrosarcoma Awareness Day First Tribute to Pete Musto

    December 27th, 2023

    First Tribute for Chondrosarcoma Awareness Day

    We are five weeks away from hosting Chondrosarcoma Awareness Day on February 6 (Shayna’s heavenly 33rd birthday). This is our international effort to educate the public about this rare bone cancer…

    Read Article

    Holiday Wishes and New Year Resolutions

    December 21st, 2023

    Just want to wish everyone the best for this holiday season. May you all cherish the moments with your family and blessings to you all for a Healthy (Pain-free) Holiday Season and a Happy New Year.

    I continue to be amazed by the caring and…

    Read Article

    Join the Fight. Chondrosarcoma Awareness Day: February 6, 2024

    December 16th, 2023

    Show Your Support for Chondrosarcoma Research and Clinical Trials

    Chondrosarcoma Awareness Day is dedicated to honor the legacy of Shayna Elise Kramer who passed away from this rare cancer in November, 2019. This February 6, would have been her…

    Read Article

    Planning for Chondrosarcoma Awareness Day: February 6, 2024

    December 4th, 2023

    Chondrosarcoma Awareness Day
    February 6, 2024
    Show Your Support for Chondrosarcoma Research and Clinical Trials

    Planning is underway to support our upcoming International Chondrosarcoma Awareness Day for February 6, 2024.

    Chondrosarcoma Awareness…

    Read Article

    A system-level approach identifies HIF-2α as a,critical regulator of chondrosarcoma progression

    November 26th, 2023

    Chondrosarcomas, malignant cartilaginous neoplasms, are capable of transitioning to highly aggressive, metastatic, and treatment-refractory states, resulting in significant patient mortality.
    Here, we aim to uncover the transcriptional program…

    Read Article

    First full Analysis of the Chondrosarcoma Patient Registry set for November 30

    November 18th, 2023

    Read Article

    Constitutive activation of EGFR is associated with tumor progression and plays a prominent role in malignant phenotype of chondrosarcoma

    October 30th, 2023

    Constitutive activation of EGFR is associated with tumor progression and plays a prominent role in malignant phenotype of chondrosarcoma Jun Qin,1 Irfan Shaukat,1 Didier Mainard,1 Patrick Netter,1 Lydia Barré,1 and Mohamed Ouzzine1

    Author…

    Read Article

    Call for Action: Join the Chondrosarcoma Patient Registry before the first full analysis set for November 30.

    October 29th, 2023

    Chondrosarcoma Patient Registry

    Homepage

    On November 30 the Chondrosarcoma will conduct the first full statistical analysis of the Chondrosarcoma Patient Registry. The analysis will focus on detailed patient profiling. In…

    Read Article

    Videos from Virtual Dialogue 5 are posted on the Web Site.

    October 27th, 2023

    Videos from Virtual Dialogue 5 are posted on the Web Site.

    We invite you to go to the Chondrosarcoma Foundation web site to review the presentations and the open discussion from the Fifth International Virtual Dialogue recently held on October 4….

    Read Article

    New Publication: Chondrosarcoma: What You Need to Know

    October 26th, 2023

    New Publication: Chondrosarcoma: What You Need to Know

    A third publication created by the Chondrosarcoma Foundation’s Patient, Family, Caregiver Advisory Board and the Marketing / Graphics team at Inhibrx provides straightforward information on…

    Read Article